Hicks Melanie D, Vasudev Milind, Bishop Jessica L, Garcia Natalie, Chowdhury Farshad, Pham Tiffany T, Heslop Gabriela, Greene Benjamin, Jeyarajan Hari, Grayson Jessica W, Goddard Julie A, Tjoa Tjoson, Haidar Yarah, Thomas Carissa M
Department of Otolaryngology-Head and Neck Surgery University of Alabama at Birmingham Birmingham Alabama USA.
School of Medicine University of California Irvine School of Medicine Irvine California USA.
OTO Open. 2023 Oct 17;7(4):e86. doi: 10.1002/oto2.86. eCollection 2023 Oct-Dec.
To explore if antiplatelet or anticoagulant therapy increases the risk of transfusion requirement or postoperative hematoma formation in patients undergoing microvascular reconstruction for head and neck defects.
Retrospective cohort study.
Departments of Otolaryngology-Head and Neck Surgery at the University of Alabama at Birmingham, the University of Colorado, and the University of California Irvine.
A multi-institutional, retrospective review on microvascular reconstruction of the head and neck between August 2013 to July 2021. Perioperative antithrombotic data were collected to examine predictors of postoperative transfusion and hematoma.
A total of 843 free flaps were performed. Preoperative hemoglobin, hematocrit, operative time, and flap type were positive predictors of postoperative transfusion in both bivariate ( < .0001) and multivariate analyses ( < .0001). However, neither anticoagulation nor antiplatelet therapy were predictive of postoperative transfusion rates and hematoma formation.
Antithrombotic regimens do not increase the risk of postoperative transfusion or hematoma in head and neck microvascular reconstruction. Based on this limited data, perioperative antithrombotic regimens can be considered in patients who may otherwise be at risk for these postoperative complications.
探讨抗血小板或抗凝治疗是否会增加接受头颈部缺损微血管重建手术患者的输血需求风险或术后血肿形成风险。
回顾性队列研究。
阿拉巴马大学伯明翰分校、科罗拉多大学和加利福尼亚大学欧文分校的耳鼻咽喉-头颈外科。
对2013年8月至2021年7月期间头颈部微血管重建手术进行多机构回顾性研究。收集围手术期抗栓数据,以检查术后输血和血肿的预测因素。
共进行了843例游离皮瓣移植手术。术前血红蛋白、血细胞比容、手术时间和皮瓣类型在双变量分析(<0.0001)和多变量分析(<0.0001)中均为术后输血的阳性预测因素。然而,抗凝治疗和抗血小板治疗均不能预测术后输血率和血肿形成。
抗栓方案不会增加头颈部微血管重建术后输血或血肿的风险。基于这些有限的数据,对于可能有这些术后并发症风险的患者,可以考虑围手术期抗栓方案。